Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04900844 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety and Efficacy of the CGuard™ Carotid Stent System in Carotid Artery Stenting

Study acronym: C-Guardians
StatusActive, Not Recruiting
PhaseNot applicable
SponsorInspireMD
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 315 to confirmed 317
    • Study sites: 17 to 18
    v7
  2. Study sites: 9 to 17v6
  3. Study sites: 4 to 9
    • Eligibility criteria expanded, about 1 word
    v5
  4. Study sites: 3 to 4v4
  5. Study sites: 2 to 3v3
  6. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 2
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
InspireMD
3 trials monitored
See all monitored trials
The objective of this pivotal study is to evaluate the safety and efficacy of the CGuard™ Carotid Stent System in the treatment of carotid artery stenosis in symptomatic and asymptomatic patients undergoing carotid artery stenting (CAS) to a performance goal developed from published CAS literature.
Trial Details
NCT Number NCT04900844
Lead Sponsor InspireMD
Conditions
(from sponsor)		 Carotid Artery Stenosis
Related terms Carotid Artery Diseases, Carotid Stenosis, Cerebrovascular Disorders, Constriction, Pathologic
Enrollment 317 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov